BMC Infectious Diseases

Table 4 Overall concordance (%) of susceptibility category agreement for all EQA distributions and methods 2007–2011 and 2012–2015 (no EQA in 2013)

From: Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data

	2007–2011			2012–2015 (no EQA in 2013)^a
	All methods (n = 131)^b	Etest (n = 72)^c	Agar dilution (n = 26)	All methods (n = 66)^b	Etest (n = 52)^c	Agar dilution (n = 11)
Azithromycin	88	85	97	83	80	92
Cefixime^d	95	93	99	91	91	91
Ceftriaxone	98	97	98	96	97	96
Ciprofloxacin	95	96	97	96	96	96
Spectinomycin	99	99	99	99	99	100

^a2016 results not included as only two laboratories performed agar dilution in 2016 so concordance was not calculated
^bIncludes disk diffusion results
^cSome countries have also used other MIC gradient strip tests
^dNot tested prior to 2010

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com